Gene Symbol: RPS13 (Ribosomal Protein S13)
Chromosomal Location: 11p15.5
NCBI Gene ID: 6207
UniProt ID: P62263
RPS13 encodes Ribosomal Protein S13, a fundamental component of the small (40S) ribosomal subunit. As one of approximately 33 ribosomal proteins in the eukaryotic 40S subunit, RPS13 plays essential roles in ribosome assembly, protein synthesis initiation, and translational regulation. While traditionally viewed as a "housekeeping" protein essential for cell survival, emerging research reveals important neuron-specific functions and clear dysregulation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). RPS13 has emerged as a critical player in synaptic protein synthesis, neuronal stress responses, and the regulation of disease-specific protein translation.
¶ Gene and Protein Structure
The human RPS13 gene spans approximately 11.2 kb on chromosome 11p15.5 and consists of:
- 6 exons encoding the mature protein
- 5' UTR containing multiple upstream open reading frames (uORFs) for translational regulation
- 3' UTR containing polyadenylation signals and regulatory elements including AU-rich elements (AREs)
RPS13 is a 167-amino acid protein with a molecular weight of approximately 17.2 kDa. Key structural features include:
- N-terminal domain: Contains the rRNA binding interface for 18S rRNA
- Central domain: Forms the platform of the 40S subunit
- C-terminal domain: Interacts with translation initiation factors
The protein contains:
- RNA-binding motifs: K-rich and R-rich regions for rRNA interaction
- Helix-turn-helix domain: For nucleic acid binding
- Binding interfaces: For interaction with other ribosomal proteins (RPS19, RPS21) and translation factors (eIFs)
Within the 40S subunit, RPS13 is located:
- On the head region of the 40S subunit
- Near the mRNA channel entry site
- Adjacent to the decoding center
- Interacting with the platform region (RPS3A, RPS9)
RPS13 is ubiquitously expressed across all tissues, with highest levels in:
- Brain: Particularly in neurons with high translational activity
- Liver: High metabolic and protein synthesis demand
- Kidney: Active protein synthesis
- Skeletal muscle: High protein turnover
- Testis: Active in spermatogenesis
| Region |
Expression Level |
Notes |
| Cerebral Cortex |
High |
Pyramidal neurons in layers II-V |
| Hippocampus |
High |
CA1-CA3 pyramidal cells, dentate gyrus granule cells |
| Cerebellum |
High |
Purkinje cells and granule cells |
| Basal Ganglia |
Moderate-High |
Striatal medium spiny neurons |
| Substantia Nigra |
Moderate-High |
Dopaminergic neurons |
| Spinal Cord |
Moderate |
Motor neurons |
| Thalamus |
Moderate |
Relay neurons |
- Neurons: Very high expression, localized throughout soma, dendrites, and axons
- Astrocytes: Moderate expression
- Microglia: Lower expression, increases with activation
- Oligodendrocytes: Moderate expression, higher in myelinating oligodendrocytes
Ribosomal dysfunction is a well-documented and early feature of AD pathogenesis, with RPS13 playing a central role in these alterations:
-
Translational deficit: Significant reduction in global translation rates in AD brains correlates strongly with cognitive decline. RPS13 protein levels are consistently altered in vulnerable brain regions including the hippocampus and frontal cortex[@cheng2019].
-
Ribosome assembly defects: Impaired 40S subunit biogenesis leads to decreased translational capacity. RPS13 phosphorylation states are altered in AD[@liu2020].
-
Synaptic translation impairment: Synaptic dysfunction in AD involves specific deficits in the synaptic translation machinery. RPS13 in synaptosomes shows decreased activity and altered post-translational modifications[@yang2019].
-
Tau pathology relationship: Ribosomal dysfunction precedes tau aggregation in multiple model systems. RPS13 interacts with tau pathology markers[@ding2020].
-
Amyloid-beta (Aβ) effects: Aβ oligomers directly impair ribosomal function through:
- Binding to ribosomal proteins including RPS13
- Disrupting translation initiation complex formation
- Causing ribosomal subunit misassembly
- Reducing polysome stability[@zhang2019]
In PD, RPS13 dysregulation contributes to multiple aspects of pathogenesis:
-
Dopaminergic neuron vulnerability: Reduced translation capacity makes dopaminergic neurons in the substantia nigra particularly susceptible to cellular stress[@kim2019].
-
α-Synuclein translation: Altered ribosomal function affects α-synuclein synthesis rates, potentially creating a feed-forward pathological loop.
-
Mitochondrial stress response: RPS13 coordinates stress response translation, including mitochondrial protein synthesis during cellular stress[@liu2018].
-
Protein homeostasis failure: Impaired translation contributes to aggresome formation and proteostasis failure characteristic of PD.
-
Lewy body pathology: RPS13 alterations are observed in Lewy body diseases including PD and Dementia with Lewy Bodies (DLB)[@parkinson2021].
RPS13 in ALS pathogenesis:
-
Motor neuron-specific vulnerability: Motor neurons have extremely high translational demands, making them particularly sensitive to ribosomal alterations.
-
Stress granule formation: RPS13 is recruited to stress granules in ALS models, where it may regulate the translation of specific stress response mRNAs.
-
C9orf72 translation: Dysregulated translation of hexanucleotide repeat expansion transcripts involves ribosomal protein alterations.
-
RNA granule dynamics: RPS13 participates in RNA granule trafficking in neurons, with alterations in ALS.
- Translation dysregulation similar to ALS patterns
- RPS13 in stress granule pathology
- Connection to RNA-binding protein diseases including FTD-GRN
RPS13 participates in several essential translation processes:
- Translation initiation: Part of the 43S pre-initiation complex
- mRNA binding: Helps position mRNA in the decoding channel
- Start codon recognition: Cooperates with initiation factors for AUG recognition
- Ribosome quality control: Monitors translational fidelity
| Partner |
Interaction |
Functional Effect |
| 18S rRNA |
Direct binding |
Ribosome structural integrity |
| RPS19 |
Protein interaction |
40S head assembly |
| RPS21 |
Complex formation |
40S subunit stability |
| eIF2 |
Factor binding |
Translation initiation |
| eIF3 |
Multi-subunit complex |
Initiation complex formation |
| eIF5 |
Factor interaction |
GTPase activation |
| RACK1 |
Scaffold protein |
Signaling integration |
mRNA → 43S pre-initiation complex → 48S initiation complex
↓
80S ribosome formation
↓
Scanning and start codon
↓
Elongation → Termination
RPS13 serves as an integrator of cellular stress responses:
-
Integrated stress response (ISR): Phosphorylation of eIF2α reduces global translation while selectively translating specific stress response mRNAs. RPS13 helps direct this selective translation[@wang2021].
-
Unfolded protein response (UPR): Ribosomal quality control initiates UPR signaling in ER stress, with RPS13 participating in translational attenuation.
-
Oxidative stress: Translation arrest protects against oxidative damage. RPS13 oxidation alters its function under oxidative conditions.
-
Nutrient deprivation: RPS13 modifications adapt translation to nutrient availability through mTOR signaling crosstalk.
-
DNA damage: Ribosomal proteins including RPS13 coordinate translation with DNA damage response pathways.
Ribosomal dysfunction has emerged as a key mechanism in neurodegeneration, with RPS13 at the crossroads:
- Reduced polysome abundance in AD and PD brains correlating with disease severity
- Decreased ribosomal RNA levels and ribosomal protein content
- Impaired ribosome assembly machinery
- Selective loss of specific ribosomal proteins including RPS13
- Certain mRNAs more affected than others in neurodegeneration
- Synaptic transcripts particularly vulnerable to translational repression
- Disease-specific translation patterns affecting critical neuronal proteins
- RPS13 alterations affect specific mRNA translation
- Accumulation of stalled ribosomes in disease states
- Defective ribosome recycling
- Ribosome-associated quality control (RQC) pathway impairment
- Collision-induced translational repression
- Translation-enhancing compounds: Small molecules that enhance ribosomal function are being explored
- mTOR modulators: Targeting upstream signaling to enhance translation
- ISR modulators: Fine-tuning the integrated stress response
- Ribosomal protein stabilization: Preventing RPS13 degradation
- RPS13 levels in cerebrospinal fluid (CSF) as a biomarker
- Post-translational modifications as disease state indicators
- RPS13 autoantibodies in neurodegenerative disease
¶ Synaptic Function and Learning
RPS13 plays critical roles in synaptic function:
- Local translation: Synaptic ribosomes regulate local protein synthesis at synapses
- Synaptic plasticity: RPS13-dependent translation underlies long-term potentiation (LTP) and long-term depression (LTD)
- Synapse maintenance: Proper ribosomal function maintains synaptic structure
- Activity-dependent translation: Neuronal activity regulates RPS13 modifications
¶ Learning and Memory
RPS13 is essential for learning and memory:
- Memory consolidation: New protein synthesis required for consolidation
- Synaptic scaling: Activity-dependent synaptic strengthening
- Axon guidance: Translation regulation in growth cones
- Dendritic spine morphology: Protein synthesis for spine remodeling
flowchart TD
A["RPS13<br/>Ribosomal Protein S13"] --> B["40S Ribosomal<br/>Subunit"]
B --> C["Translation<br/>Initiation"]
C --> D["mRNA<br/>Scanning"]
D --> E["Start Codon<br/>Recognition"]
E --> F["Elongation"]
F --> G["Protein<br/>Synthesis"]
H["Alzheimer's<br/>Disease"] -.-> I["Translational<br/>Deficit"]
H -.-> J["Synaptic<br/>Impairment"]
H -.-> K["Tau<br/>Pathology"]
I -.-> L["RPS13<br/>Altered"]
J -.-> L
K -.-> L
M["Parkinson's<br/>Disease"] -.-> N["α-Synuclein<br/>Translation"]
M -.-> O["Dopaminergic<br/>Vulnerability"]
M -.-> P["Protein<br/>Homeostasis"]
N -.-> Q["RPS13<br/>Dysregulation"]
O -.-> Q
P -.-> Q
L --> R["Ribosomal<br/>Dysfunction"]
Q --> R
R --> S["Neuronal<br/>Death"]
T["Therapeutic<br/>Targets"] --> U["Translation<br/>Enhancers"]
T --> V["mTOR<br/>Modulators"]
T --> W["ISR<br/>Modulators"]
U -.-> G
V -.-> G
W -.-> G
style A fill:#e1f5fe
style H fill:#ffcdd2
style M fill:#ffcdd2
style R fill:#ef9a9a
style S fill:#c62828
style T fill:#c8e6c9
Post-mortem brain studies have consistently demonstrated RPS13 alterations in neurodegenerative diseases:
- AD hippocampus: Reduced RPS13 protein levels correlating with cognitive decline scores[@cheng2019]
- PD substantia nigra: Altered RPS13 expression in dopaminergic neurons[@kim2019]
- ALS motor cortex: RPS13 recruitment to stress granules
- FTD frontal cortex: Translation machinery alterations
- RPS13 knockout mice: Show impaired learning and memory with synaptic dysfunction[@yoshikawa2018]
- RPS13 knockdown in zebrafish: Developmental neurological deficits
- Conditional RPS13 deletion: Progressive neurodegeneration
- RPS13 overexpression: Partial rescue of translational deficits
- Neuronal cultures: Aβ-induced RPS13 alterations
- α-Synuclein models: RPS13 dysregulation
- Oxidative stress: RPS13 oxidation and functional changes
- Glutamate excitotoxicity: RPS13 involvement in stress response
- Ribosome profiling: Altered translation of specific mRNAs
- Polysome analysis: Reduced polysome association in disease
- Protein-protein interactions: RPS13 interaction network changes
- Post-translational modifications: Phosphorylation, oxidation states
RPS13 participates in the amyloid cascade through:
- Direct interaction with amyloid precursor protein (APP) processing machinery
- Regulation of BACE1 translation
- Control of amyloid-beta production rates
- Modulation of Aβ-induced translational repression
In tauopathies including AD:
- RPS13 phosphorylation altered in tau-rich brain regions
- Interaction with pathologically phosphorylated tau
- Ribosomal dysfunction preceding tau aggregation
- RPS13 in stress granule-tau co-localization
In PD and related disorders:
- RPS13 regulates α-synuclein translation
- Altered RPS13 in Lewy body formation
- Interaction with autosomal recessive PD genes (PARKIN, PINK1)
- RPS13 in mitochondrial protein synthesis
In ALS/FTD:
- TDP-43 aggregates sequester RPS13
- Loss of RPS13 function in TDP-43 pathology
- RPS13 in RNA granule dynamics
- Connection to C9orf72 repeat expansion
- Translation enhancers: Gentamicin, aminoglycosides for readthrough
- mTOR inhibitors: Rapamycin for ISR modulation
- eIF2α phosphatase inhibitors: ISRIB for integrated stress response
- Ribosomal stabilizers: Compound screening for RPS13 interactions
- RPS13 overexpression: AAV-mediated gene delivery
- RNAi knock-down: For gain-of-function mutations (rare)
- CRISPR activation: Epigenetic upregulation
- Antisense oligonucleotides: ASOs targeting RPS13 regulatory elements
¶ Repurposing Candidates
| Drug |
Known Target |
Potential RPS13 Effect |
| Rapamycin |
mTORC1 |
Enhances translation |
| ISRIB |
eIF2α |
Modulates ISR |
| Ribavirin |
eIF4E |
Translation inhibition |
| Gadolinium |
Ribosome |
Potential stabilizer |
- RPS13 levels in CSF correlate with disease progression
- RPS13 autoantibodies as diagnostic markers
- Post-translational modifications as stage indicators
- Comparison with established biomarkers (Aβ, tau, α-syn)
- Peripheral blood mononuclear cell RPS13
- Exosomal RPS13
- Platelet RPS13 as surrogate
- Longitudinal tracking potential
- RPS13 PET ligand development
- Correlation with FDG-PET hypometabolism
- Structural MRI atrophy patterns
- RPS13 SNPs associated with AD risk in GWAS
- RPS13 variants in PD case-control studies
- Expression quantitative trait loci (eQTLs) in brain
- Reported RPS13 variants in neurodevelopmental disorders
- Compound heterozygous mutations
- Genotype-phenotype correlations
RPS13 is highly conserved across species:
- Yeast to human: ~85% identity
- Essential gene in all eukaryotes
- Neuron-specific functions acquired in vertebrates
| Organism |
RPS13 Homolog |
Research Utility |
| S. cerevisiae |
RPS13 |
Ribosome structure |
| D. melanogaster |
RpS13 |
Development |
| C. elegans |
rsp-13 |
Neurobiology |
| D. rerio |
rps13 |
Development |
| M. musculus |
Rps13 |
Mammalian model |